320 related articles for article (PubMed ID: 26905334)
1. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
[TBL] [Abstract][Full Text] [Related]
2. A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition.
Tanaka A; Muto S; Konno M; Itai A; Matsuda H
Cancer Res; 2006 Jan; 66(1):419-26. PubMed ID: 16397257
[TBL] [Abstract][Full Text] [Related]
3. IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment.
Kinose Y; Sawada K; Makino H; Ogura T; Mizuno T; Suzuki N; Fujikawa T; Morii E; Nakamura K; Sawada I; Toda A; Hashimoto K; Isobe A; Mabuchi S; Ohta T; Itai A; Morishige K; Kurachi H; Kimura T
Mol Cancer Ther; 2015 Apr; 14(4):909-19. PubMed ID: 25637316
[TBL] [Abstract][Full Text] [Related]
4. Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.
Yang M; Zou J; Zhu H; Liu S; Wang H; Bai P; Xiao X
Oncol Rep; 2015 May; 33(5):2190-8. PubMed ID: 25760800
[TBL] [Abstract][Full Text] [Related]
5. An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells.
Uota S; Zahidunnabi Dewan M; Saitoh Y; Muto S; Itai A; Utsunomiya A; Watanabe T; Yamamoto N; Yamaoka S
Cancer Sci; 2012 Jan; 103(1):100-6. PubMed ID: 21951590
[TBL] [Abstract][Full Text] [Related]
6. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.
Huang S; Robinson JB; Deguzman A; Bucana CD; Fidler IJ
Cancer Res; 2000 Oct; 60(19):5334-9. PubMed ID: 11034066
[TBL] [Abstract][Full Text] [Related]
7. Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.
Assar EA; Vidalle MC; Chopra M; Hafizi S
Tumour Biol; 2016 Jul; 37(7):9375-85. PubMed ID: 26779636
[TBL] [Abstract][Full Text] [Related]
8. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways.
Ma K; Wang C; Geng Q; Fan Y; Ning J; Yang H; Dong X; Dong D; Guo Y; Wei X; Li E; Wu Y
Oncol Rep; 2016 Jun; 35(6):3505-13. PubMed ID: 27035232
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IkappaB kinase beta restrains oncogenic proliferation of pancreatic cancer cells.
Ochiai T; Saito Y; Saitoh T; Dewan MZ; Shioya A; Kobayashi M; Kawachi H; Muto S; Itai A; Uota S; Eishi Y; Yamamoto N; Tanaka S; Arii S; Yamaoka S
J Med Dent Sci; 2008 Mar; 55(1):49-59. PubMed ID: 19845150
[TBL] [Abstract][Full Text] [Related]
12. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
[TBL] [Abstract][Full Text] [Related]
13. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
14. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
Oka D; Nishimura K; Shiba M; Nakai Y; Arai Y; Nakayama M; Takayama H; Inoue H; Okuyama A; Nonomura N
Int J Cancer; 2007 Jun; 120(12):2576-81. PubMed ID: 17290398
[TBL] [Abstract][Full Text] [Related]
15. IκB kinase-β inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice.
Lennikov A; Hiraoka M; Abe A; Ohno S; Fujikawa T; Itai A; Ohguro H
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6365-73. PubMed ID: 25205865
[TBL] [Abstract][Full Text] [Related]
16. IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma.
Ogawa H; Azuma M; Muto S; Nishioka Y; Honjo A; Tezuka T; Uehara H; Izumi K; Itai A; Sone S
Clin Exp Allergy; 2011 Jan; 41(1):104-15. PubMed ID: 20573155
[TBL] [Abstract][Full Text] [Related]
17. Apigenin blocks IKKα activation and suppresses prostate cancer progression.
Shukla S; Kanwal R; Shankar E; Datt M; Chance MR; Fu P; MacLennan GT; Gupta S
Oncotarget; 2015 Oct; 6(31):31216-32. PubMed ID: 26435478
[TBL] [Abstract][Full Text] [Related]
18. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
19. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
20. Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.
Ataie-Kachoie P; Badar S; Morris DL; Pourgholami MH
Mol Cancer Res; 2013 Oct; 11(10):1279-91. PubMed ID: 23858099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
